KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to Oregon

HB2385 • 2025

Prohibits drug manufacturers from interfering directly or indirectly with a pharmacy or drug outlet acquiring 340B drugs, delivering 340B drugs to certain health care providers or dispensing 340B drugs.

Prohibits drug manufacturers from interfering directly or indirectly with a pharmacy or drug outlet acquiring 340B drugs, delivering 340B drugs to certain health care providers or dispensing 340B drugs.

Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor
Representative Nosse,, Senator Patterson, Representative Diehl,, Gamba,, Gomberg,, Javadi,, Pham H,, Senator Manning Jr,
Last action
2025-06-23
Official status
Chapter Number Assigned
Effective date
Not listed

Plain English Breakdown

The plain English breakdown is still being put together. The official documents below are already here.

Bill History

  1. 2025-06-23 House

    Chapter 297, (2025 Laws): effective on the 91st day following adjournment sine die.

  2. 2025-06-11 House

    Governor signed.

  3. 2025-06-03 House

    Speaker signed.

  4. 2025-06-03 Senate

    President signed.

  5. 2025-06-02 House

    House concurred in Senate amendments and repassed bill. Ayes, 35; Nays, 20--Boice, Boshart Davis, Breese-Iverson, Cate, Drazan, Edwards, Elmer, Evans, Harbick, Helfrich, Levy B, Lewis, Osborne, Owens, Reschke, Ruiz, Scharf, Skarlatos, Smith G, Yunker; Excused, 4--Marsh, McIntire, Nguyen H, Wallan.

  6. 2025-05-28 Senate

    Motion to substitute Minority Report for Committee Report failed. Ayes, 12; Nays, 18--Broadman, Campos, Frederick, Gelser Blouin, Golden, Gorsek, Jama, Lieber, Manning Jr, Meek, Neron Misslin, Patterson, Pham, Prozanski, Reynolds, Sollman, Taylor, President Wagner.

  7. 2025-05-28 Senate

    Third reading. Carried by Patterson. Passed. Ayes, 17; Nays, 13--Anderson, Bonham, Broadman, Girod, Hayden, Linthicum, McLane, Nash, Robinson, Smith DB, Starr, Thatcher, Weber.

  8. 2025-05-28 Senate

    Vote explanation(s) filed by Sollman.

  9. 2025-05-27 Senate

    Second reading.

  10. 2025-05-23 Senate

    Recommendation: Do pass with amendments to the A-Eng bill. (Printed B-Eng.) Hayden, Linthicum not concurring.

  11. 2025-05-23 Senate

    Minority Recommendation: Do pass with different amendments to the A-Eng bill. (Printed B-Eng. Minority)

  12. 2025-05-13 Senate

    Work Session held.

  13. 2025-05-08 Senate

    Public Hearing held.

  14. 2025-05-06 Senate

    Public Hearing held.

  15. 2025-04-15 Senate

    First reading. Referred to President's desk.

  16. 2025-04-15 Senate

    Referred to Health Care.

  17. 2025-04-14 House

    Third reading. Carried by Nosse. Passed. Ayes, 37; Nays, 18--Boice, Boshart Davis, Breese-Iverson, Drazan, Edwards, Elmer, Harbick, Helfrich, Levy B, Lewis, McIntire, Osborne, Reschke, Scharf, Skarlatos, Smith G, Wallan, Yunker; Excused, 4--Cate, Evans, Nguyen H, Walters; Excused for Business of the House, 1--Owens.

  18. 2025-04-14 House

    Vote explanation(s) filed by Nelson.

  19. 2025-04-09 House

    Rules suspended. Carried over to April 14, 2025 Calendar.

  20. 2025-04-08 House

    Second reading.

  21. 2025-04-07 House

    Recommendation: Do pass with amendments and be printed A-Engrossed.

  22. 2025-04-01 House

    Work Session held.

  23. 2025-03-11 House

    Public Hearing held.

  24. 2025-01-17 House

    Referred to Behavioral Health and Health Care.

  25. 2025-01-13 House

    First reading. Referred to Speaker's desk.

Official Summary Text

<b>Digest: The Act tells drug makers not to take actions that make it hard for a drug store to get certain drugs for health care providers, deliver the drugs to the providers, or dispense the drugs. Makes it a civil penalty to violate the Act. (Flesch Readability Score: 71.0).</b>
[<i>Digest: The Act tells drug makers not to take actions that make it hard for a drug store to get certain drugs for health care providers, deliver the drugs to the providers or dispense the drugs. (Flesch Readability Score: 62.5).</i>]
Prohibits drug manufacturers from interfering directly or indirectly with a pharmacy or drug outlet acquiring 340B drugs, delivering 340B drugs to certain health care providers or dispensing 340B drugs. Prohibits drug manufacturers from requiring utilization review data from a drug outlet or pharmacy as a condition of the acquisition, delivery or dispensation of a 340B drug.
<b>Creates a civil penalty imposed by the State Board of Pharmacy for violations of the provisions of the Act.</b>
Takes effect on the 91st day following adjournment sine die.
Relating to: Relating to restrictions on 340B covered entities; and prescribing an effective date.
Current location: Chapter Number Assigned